Year: 2022
Type: article
Abstract: Lactobacilli constitute the dominant microbiota in many fermented foods and comprise widely used probiotics. However, these bacteria cause rare infections mostly in diabetic and immunocompromised subjects in presence of risk factors such as prosthetic hearth valves and dental procedures or caries. The scope of this survey was re-assessing the pathogenic potential of lactobacilli based on the infection case reports published in the last three years. In 2019, 2020, and 2021, total of 17, 15, and 16 cases, respectively, including endocarditis, bacteremia, and other infections, were reported. These annual numbers are higher than those observed previously. Lacticaseibacillus rhamnosus (13 cases), comprising strain GG (ATCC 53103) with established applications in healthcare, L. paracasei (7 cases), Lactobacillus acidophilus (5 cases), L. jensenii (5 cases), Lactiplantibacillus plantarum (3 cases), L. paraplantarum, L. delbrueckii subsp. delbrueckii, L. gasseri, L. paragasseri, Limosilactobacillus fermentum, and L. reuteri (1 case each) were involved. Virulence characterization of two strains that caused infections, a derivative of L. rhamnosus GG and L. paracasei LP10266, indicated that increased biofilm-forming capacity favors pathogenicity and it is determined by variable genetic traits. This survey highlights that the strains of lactobacilli that cause infections are little characterized genetically. Instead, to avoid that these bacteria become a hazard, genetic stability should be periodically re-evaluated by whole genome sequencing (WGS) to ensure that only non-pathogenic variants are administered to vulnerable individuals.
Source: Nutrients
DOI: 10.3390/nu14061178
Language: English
Subfield: Food Science
Domain: Life Sciences
Keywords: probiotic safety, Lactobacillus rhamnosus GG, Lactobacillus paracasei, Lactobacillus plantarum, Lactobacillus paraplantarum, Lactobacillus delbrueckii subsp. delbrueckii, Lactobacillus gasseri, Lactobacillus paragasseri, Lactobacillus fermentum, Lactobacillus reuteri, Lactobacillus jensenii, Lactobacillus acidophilus, endocarditis, bacteremia, biofilm formation, virulence, genetic stability, whole genome sequencing, immunocompromised patients, diabetes mellitus, dental treatment, prosthetic heart valves
Open Access status: gold
Estimated APC paid: $2,722
OpenAlex ID: W4221028908
